Ignite Creation Date:
2024-05-06 @ 11:01 AM
Last Modification Date:
2024-10-26 @ 12:39 PM
Study NCT ID:
NCT03410693
Status:
COMPLETED
Last Update Posted:
2022-09-28
First Post:
2018-01-19
Brief Title:
Study of Rogaratinib BAY1163877 vs Chemotherapy in Patients With FGFR Fibroblast Growth Factor Receptor-Positive Locally Advanced or Metastatic Urothelial Carcinoma
Sponsor:
Bayer
Organization:
Bayer
Organization Data
Organization:
Bayer
Class:
INDUSTRY
Study ID:
17403
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Bayer
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None